Dr. Reddy's Laboratories Ltd (RDY) vs Takeda Pharmaceutical Co. (TAK)
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
Dr. Reddy's Laboratories Ltd and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $10.7B — 5.8× the size. Takeda Pharmaceutical Co. trades at the lower P/E: 29.6× against 32.9×. Takeda Pharmaceutical Co. grew revenue faster over the last twelve months: 0.66% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs 7.12%) and the higher return on invested capital (5.89% vs 2.88%). Only Takeda Pharmaceutical Co. pays a dividend (1.57%). Across the 23 metrics below, Takeda Pharmaceutical Co. leads on 12 and Dr. Reddy's Laboratories Ltd on 11.
Valuation
Profitability
| Metric | RDY | TAK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 50.00% | 65.85% | 53.94% |
| Operating margin | 10.91% | 11.61% | 0.00% |
| Net margin | 9.81% | 7.12% | 0.00% |
| Free cash flow margin | 4.05% | 24.74% | 0.00% |
| Return on equity | 8.21% | 4.42% | (0.40%) |
| Return on assets | 5.55% | 2.15% | (3.32%) |
| Return on invested capital | 5.89% | 2.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack